<DOC>
	<DOCNO>NCT00884949</DOCNO>
	<brief_summary>This multicenter , open-label study design assess safety , dose-response use pharmacokinetic ( PK ) pharmacodynamic ( PD ) measure , clinical efficacy BMN 110 subject 5 18 year age , diagnose Mucopolysaccharidosis IVA ( MPS IVA ) .</brief_summary>
	<brief_title>A Study Evaluate Safety , Tolerability Efficacy BMN 110 Subjects With Mucopolysaccharidosis IVA</brief_title>
	<detailed_description />
	<mesh_term>Mucopolysaccharidoses</mesh_term>
	<criteria>Documented history reduce GALNS activity relative normal range laboratory perform assay , document result molecular genetic test confirm diagnosis MPS IVA . Willing able provide write , sign informed consent , case subject age 16 year , provide write assent ( require ) write informed consent legally authorize representative nature study explain , prior researchrelated procedure . Between 5 18 year age , inclusive . Sexually active subject must willing use acceptable method contraception participate study . Females childbearing potential must negative pregnancy test Screening willing additional pregnancy test study . Willing perform study procedure physically possible . Previous hematopoietic stem cell transplant ( HSCT ) . Has know hypersensitivity BMN 110 excipients . Pregnant breastfeed Screening plan become pregnant ( self partner ) time study . Use investigational product investigational medical device within 30 day prior Screening , requirement investigational agent prior completion schedule study assessment . Concurrent disease condition would interfere study participation safety , include , limited , symptomatic cervical spine instability . Any condition , view Principal Investigator ( PI ) , place subject high risk poor treatment compliance complete study .</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>Mucopolysaccharidosis IV type A</keyword>
	<keyword>MPS IV Type A</keyword>
	<keyword>Mucopolysaccharidosis IVA</keyword>
	<keyword>MPS IVA</keyword>
	<keyword>Morquio A Syndrome</keyword>
	<keyword>Lysosomal Storage Disorder</keyword>
	<keyword>LSD</keyword>
	<keyword>N-acetylgalactosamine-6-sulfatase</keyword>
	<keyword>N-acetylgalactosamine-6-sulfate sulfatase</keyword>
	<keyword>galactose-6-sulfatase</keyword>
	<keyword>GALNS</keyword>
	<keyword>enzyme replacement therapy</keyword>
	<keyword>ERT</keyword>
</DOC>